FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Aug 31, 2026 · FilingSight Research

Market Brief — August 31, 2026

Risk-on · Supportive. 25 Buy / 123 Hold / 34 Sell across 182 names. Top conviction: CME.

MacroDaily BriefRates

Market Brief — August 31, 2026

Auto-generated by FilingSight from live FRED macro data and the latest SEC-derived company reports.

Macro regime

Risk-on · Supportive.

Gauge Status Detail
Growth & Recession Gauge Mixed / caution Mixed / caution. Payrolls softening.
Inflation Regime Moderating Moderating. Headline CPI +3.3% YoY, core +2.5% YoY; 5Y breakeven 2.30%.
Financial Conditions Neutral Neutral. VIX 14.51, BAA-10Y credit spread 1.60pp.
Policy Stance Near neutral Near neutral. Fed funds 3.63%, real rate 1.16%.

Rates & inflation

Fed funds 3.63%, headline CPI YoY 3.3%, VIX 14.5, yield curve upward-sloping.

Coverage breadth

Across 182 tracked names: 25 bullish, 123 neutral, 34 bearish outlook.

Highest-conviction bullish names:

  • CME (CME Group Inc.) — Buy, composite score 34, confidence 81%.
  • BKNG (Booking Holdings) — Buy, composite score 32, confidence 83%.
  • GOOGL (Alphabet Inc.) — Buy, composite score 31, confidence 65%.
  • CF (CF Industries) — Buy, composite score 31, confidence 82%.

Most bearish names:

  • ON (ON Semiconductor Corp.) — Sell, score -46.
  • TSLA (Tesla Inc.) — Sell, score -40.
  • SBUX (Starbucks Corp.) — Sell, score -29.

What to watch

With the macro backdrop firmly risk-on amid a supportive Fed and contained 3.3% inflation, the steepening yield curve and subdued VIX provide a constructive runway for secular growth and selective cyclicals. Notably, tracked breadth skews defensive with 123 Holds, but leadership from CME, GOOGL, BKNG, and CF signals quality-risk appetite across platforms, travel, and ag-linked chemicals; watch for this narrow leadership to broaden, or fail to do so, as the market tests the next leg higher.


FilingSight is informational and educational only, generated from public data. Not investment advice.